Invention Grant
US07205118B2 Nicotinamide N-methyltransferase as a marker for colorectal cancer
有权
烟酰胺N-甲基转移酶作为结肠直肠癌的标志物
- Patent Title: Nicotinamide N-methyltransferase as a marker for colorectal cancer
- Patent Title (中): 烟酰胺N-甲基转移酶作为结肠直肠癌的标志物
-
Application No.: US11152765Application Date: 2005-06-14
-
Publication No.: US07205118B2Publication Date: 2007-04-17
- Inventor: Michael Tacke , Peter Berndt , Marie-Luise Hagmann , Johann Karl , Theresa Kott , Hanno Langen , Stefan Palme , Markus Roessler , Wolfgang Rollinger , Werner Zolg
- Applicant: Michael Tacke , Peter Berndt , Marie-Luise Hagmann , Johann Karl , Theresa Kott , Hanno Langen , Stefan Palme , Markus Roessler , Wolfgang Rollinger , Werner Zolg
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Roche Diagnostics Operations, Inc.
- Agent Marilyn L. Amick
- Priority: EP02028715 20021220
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
The present invention relates to the diagnosis of colorectal cancer. It discloses the use of the protein nicotinamide N-methyltransferase (NNMT) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring NNMT in said sample. Measurement of NNMT can, e.g., be used in the early detection or diagnosis of colorectal cancer.
Public/Granted literature
- US20060003368A1 Nicotinamide N-methyltransferase as a marker for colorectal cancer Public/Granted day:2006-01-05
Information query
IPC分类:
